hTert-immortalized endothelial cells: An important new research tool

Cell Cycle

Volumn 3, Issue 6, 2004, Pages 787-

  Price, Douglas K ^a   Figg, William D ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Molecular Pharmacology Section   (United States)

Author keywords

Aging; Angiogenesis; Endothelial; htert; Preclinical

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BEVACIZUMAB; TELOMERASE REVERSE TRANSCRIPTASE;

ANGIOGENESIS; CANCER GROWTH; CANCER INHIBITION; CELL AGING; CELL CYCLE; CELL IMMORTALIZATION; CELL SURVIVAL; CELL TRANSFORMATION; ENDOTHELIUM CELL; HUMAN; NOTE;

EID: 13244274912     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.3.6.945     Document Type: Note

References (6)

1. 1 checkpoint controls in telomerase-immortalized endothelial cells. Cell Cycle 2004; In press.
2. Yang J, Chang E, Cherry AM, Bangs CD, Oei Y, Bodnar A, et al. Human endothelial cell life extension by telomerase expression. J Biol Chem 1999; 274:26141-8.
3. Venetsanakos E, Mirza A, Fanton C, Romanov SR, Tlsty T, McMahon M. Induction of tubulogenesis in telomerase-immortalized human microvascular endothelial cells by glioblastoma cells. Exp Cell Res 2002; 273:21-33.
4. Matsushita H, Chang E, Glassford AJ, Cooke JP, Chiu CP, Tsao PS. eNOS activity is reduced in senescent human endothelial cells: Preservation by hTERT immortalization. Circ Res 2001; 89:793-8.
5. MacKenzie KL, Franco S, Naiyer AJ, May C, Sadelain M, Rafii S, et al. Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras. Oncogene 2002; 21:4200-11.
6. Young AT, Lakey JR, Murray AG, Mullen JC, Moore RB. In vitro senescence occurring in normal human endothelial cells can be rescued by ectopic telomerase activity. Transplant Proc 2003; 35:2483-5.